We find and validate mutations that others cannot…
with advanced, patented genomic probe and bioinformatic technologies.
Cytognomix continues our long track record of creating technologies for genomic medicine.
We anticipate and implement the needs of the biomedical and clinical genomics communities.
- February 27, 2017. CytoGnomix finalizes contract with Government of Canada
- Jan. 28, 2017. New version of F1000Research paper on chemotherapy response in breast cancer
- January 25, 2017. Comment from the Transforming Genetic Medicine Initiative Blog
- Jan. 23, 2017. Automated interpretation of digital pathology images is currently at an embryonic stage of development